Literature DB >> 19800126

Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes.

Sarah J Cullen1, Subramaniam Ponnappan, Usha Ponnappan.   

Abstract

The induction of key pro-inflammatory genes is regulated by the SWI/SNF class of ATP-dependent remodeling complexes. In particular, the catalytic ATPase subunit, Brg1, is distinctly involved in the chromatin remodeling required for activating pro-inflammatory genes in a temporally, ordered fashion. Despite advances in our understanding of the role for Brg1 in the kinetics of inflammatory responses, little is known about the precise mechanisms which down-regulate Brg1 activity. Biochemical studies implicate a role for the proteasome in the regulation of SWI/SNF assembly and function; however, it is unclear if proteasome-dependent mechanisms modulate its remodeling activity or recruitment to chromatin in order to regulate inflammatory gene transcription. We now demonstrate for the first time that proteasome function represents an important mechanism for limiting inducible association of Brg1 with promoters of SWI/SNF-regulated, inflammatory genes. As a result, catalytic activity of the proteasome fine-tunes the kinetics of inflammatory gene transcription by inhibiting both premature and persistent chromatin remodeling at SWI/SNF-regulated genes. These results provide mechanistic insight into the interplay between nucleosome remodeling, inflammation and proteasome, and underscore the critical role of the proteasome in controlling both extent and duration of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800126      PMCID: PMC2788002          DOI: 10.1016/j.molimm.2009.09.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  33 in total

1.  Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene.

Authors:  S Rao; E Procko; M F Shannon
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.

Authors:  Qiao Li; Anna Su; Jihong Chen; Yvonne A Lefebvre; Robert J G Haché
Journal:  Mol Endocrinol       Date:  2002-12

3.  Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.

Authors:  Vladimir R Ramirez-Carrozzi; Aaron A Nazarian; Caiyi C Li; Sarah L Gore; Rupa Sridharan; Anthony N Imbalzano; Stephen T Smale
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

4.  Mitotic inactivation of a human SWI/SNF chromatin remodeling complex.

Authors:  S Sif; P T Stukenberg; M W Kirschner; R E Kingston
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

5.  Decreased proteasome-mediated degradation in T cells from the elderly: A role in immune senescence.

Authors:  U Ponnappan; M Zhong; G U Trebilcock
Journal:  Cell Immunol       Date:  1999-03-15       Impact factor: 4.868

6.  The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.

Authors:  C Muchardt; J C Reyes; B Bourachot; E Leguoy; M Yaniv
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

7.  Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically.

Authors:  Joan Oliva; Jennifer Dedes; Jun Li; Samuel-W French; Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

8.  Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes.

Authors:  Diana A Stavreva; Waltraud G Müller; Gordon L Hager; Carolyn L Smith; James G McNally
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases.

Authors:  Federico Licastro; Giuseppina Candore; Domenico Lio; Elisa Porcellini; Giuseppina Colonna-Romano; Claudio Franceschi; Calogero Caruso
Journal:  Immun Ageing       Date:  2005-05-18       Impact factor: 6.400

10.  Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.

Authors:  Simona Saccani; Ivan Marazzi; Amer A Beg; Gioacchino Natoli
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  10 in total

Review 1.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

Review 2.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

Review 3.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

4.  An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.

Authors:  Alexandra Duverger; Frank Wolschendorf; Mingce Zhang; Fredric Wagner; Brandon Hatcher; Jennifer Jones; Randall Q Cron; Renee M van der Sluis; Rienk E Jeeninga; Ben Berkhout; Olaf Kutsch
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

5.  Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.

Authors:  Ahlam Alasiri; Jorge Abboud Guerr; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 6.  Bromodomains as therapeutic targets.

Authors:  Susanne Muller; Panagis Filippakopoulos; Stefan Knapp
Journal:  Expert Rev Mol Med       Date:  2011-09-13       Impact factor: 5.600

7.  LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Authors:  Peter G K Clark; Lucas C C Vieira; Cynthia Tallant; Oleg Fedorov; Dean C Singleton; Catherine M Rogers; Octovia P Monteiro; James M Bennett; Roberta Baronio; Susanne Müller; Danette L Daniels; Jacqui Méndez; Stefan Knapp; Paul E Brennan; Darren J Dixon
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-13       Impact factor: 15.336

8.  Retracted Article: Structural characterization of Mesobuthus martensii Karsch peptides and anti-inflammatory potency evaluation in human vascular endothelial cells.

Authors:  Man Zheng; Xiafeng Yan; Fanli Bu; Fenglei Zhang; Zhenhua Li; Jiali Cui; Jie Liu; Minya Dong
Journal:  RSC Adv       Date:  2019-06-20       Impact factor: 4.036

9.  Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib.

Authors:  A L Furfaro; S Piras; C Domenicotti; D Fenoglio; A De Luigi; M Salmona; L Moretta; U M Marinari; M A Pronzato; N Traverso; M Nitti
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

10.  LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Authors:  Peter G K Clark; Lucas C C Vieira; Cynthia Tallant; Oleg Fedorov; Dean C Singleton; Catherine M Rogers; Octovia P Monteiro; James M Bennett; Roberta Baronio; Susanne Müller; Danette L Daniels; Jacqui Méndez; Stefan Knapp; Paul E Brennan; Darren J Dixon
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2015-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.